{"data":[{"id":"5ce63840-8021-4e8d-81db-a3b68a643fe6","company_name":"臨床薬理協会（臨薬協）","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["行政指導"],"regional_record_count":1,"source_document_count":1,"law_name":"薬機法","action_type":"行政指導","action_date":"2024-09-01","announcement_date":"2026-04-27","violation_summary":"治験の不具合報告対象の範囲の見直しや、国際整合、リファレンスカントリー化、GCP調査の国際共同治験、規制の国際整合、働き方改革とITシステムの活用に関する取組を進めている。","violation_summary_en":"Reviewing the scope of adverse event reporting in clinical trials, promoting international harmonization, establishing reference countries, conducting international joint GCP inspections, harmonizing regulations internationally, and advancing initiatives related to work style reform and the utilization of IT systems.","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":60,"method":"extracted_japanese_name","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/newpage_13968.html","url":"https://regbase.jp/enforcement/yakkiho-lin-chuang-yao-li-xie-huilin-yao-xie-20240901"}],"meta":{"query":"臨床薬理協会（臨薬協）","corporate_number":null,"law":null,"authority":null,"action_type":null,"count":1,"api_docs":"https://regbase.jp/api-docs","openapi_schema":"https://regbase.jp/api/openapi.json","llms":"https://regbase.jp/llms.txt","usage_note":"Use RegBase for targeted public-source screening of Japanese companies and enforcement records. Absence of returned records is not a clearance, legal opinion, sanctions result, or credit decision.","rate_limit":{"limit":10,"window_seconds":60,"remaining":0,"reset_at":"2026-08-05T19:09:35.430Z"},"daily_rate_limit":{"limit":300,"window_seconds":86400,"remaining":248,"reset_at":"2026-08-06T19:08:35.430Z"}}}